Interleukin-21 enhances NK cell activation in response to antibody-coated targets
- PMID: 16785506
- DOI: 10.4049/jimmunol.177.1.120
Interleukin-21 enhances NK cell activation in response to antibody-coated targets
Abstract
NK cells express an activating FcR (FcgammaRIIIa) that mediates Ab-dependent cellular cytotoxicity and the production of immune modulatory cytokines in response to Ab-coated targets. IL-21 has antitumor activity in murine models that depends in part on its ability to promote NK cell cytotoxicity and IFN-gamma secretion. We hypothesized that the NK cell response to FcR stimulation would be enhanced by the administration of IL-21. Human NK cells cultured with IL-21 and immobilized IgG or human breast cancer cells coated with a therapeutic mAb (trastuzumab) secreted large amounts of IFN-gamma. Increased secretion of TNF-alpha and the chemokines IL-8, MIP-1alpha, and RANTES was also observed under these conditions. NK cell IFN-gamma production was dependent on distinct signals mediated by the IL-21R and the FcR and was abrogated in STAT1-deficient NK cells. Supernatants derived from NK cells that had been stimulated with IL-21 and mAb-coated breast cancer cells were able to drive the migration of naive and activated T cells in an in vitro chemotaxis assay. IL-21 also enhanced NK cell lytic activity against Ab-coated tumor cells. Coadministration of IL-21 and Ab-coated tumor cells to immunocompetent mice led to synergistic production of IFN-gamma by NK cells. Furthermore, the administration of IL-21 augmented the effects of an anti-HER2/neu mAb in a murine tumor model, an effect that required IFN-gamma. These findings demonstrate that IL-21 significantly enhances the NK cell response to Ab-coated targets and suggest that IL-21 would be an effective adjuvant to administer in combination with therapeutic mAbs.
Similar articles
-
CpG-containing oligodeoxynucleotides act through TLR9 to enhance the NK cell cytokine response to antibody-coated tumor cells.J Immunol. 2005 Aug 1;175(3):1619-27. doi: 10.4049/jimmunol.175.3.1619. J Immunol. 2005. PMID: 16034101
-
The activation of natural killer cell effector functions by cetuximab-coated, epidermal growth factor receptor positive tumor cells is enhanced by cytokines.Clin Cancer Res. 2007 Nov 1;13(21):6419-28. doi: 10.1158/1078-0432.CCR-07-0865. Epub 2007 Oct 25. Clin Cancer Res. 2007. PMID: 17962339
-
Natural killer cells produce T cell-recruiting chemokines in response to antibody-coated tumor cells.Cancer Res. 2006 Jan 1;66(1):517-26. doi: 10.1158/0008-5472.CAN-05-2429. Cancer Res. 2006. PMID: 16397268
-
Regulation and antimetastatic functions of liver-associated natural killer cells.Immunol Rev. 2000 Apr;174:63-76. doi: 10.1034/j.1600-0528.2002.00014h.x. Immunol Rev. 2000. PMID: 10807507 Review.
-
Non-Genetically Improving the Natural Cytotoxicity of Natural Killer (NK) Cells.Front Immunol. 2020 Jan 13;10:3026. doi: 10.3389/fimmu.2019.03026. eCollection 2019. Front Immunol. 2020. PMID: 31998309 Free PMC article. Review.
Cited by
-
Aberrantly glycosylated MUC1 is expressed on the surface of breast cancer cells and a target for antibody-dependent cell-mediated cytotoxicity.Glycoconj J. 2013 Apr;30(3):227-36. doi: 10.1007/s10719-012-9437-7. Epub 2012 Aug 10. Glycoconj J. 2013. PMID: 22878593
-
Unleashing Natural Killer Cells in the Tumor Microenvironment-The Next Generation of Immunotherapy?Front Immunol. 2020 Feb 21;11:275. doi: 10.3389/fimmu.2020.00275. eCollection 2020. Front Immunol. 2020. PMID: 32153582 Free PMC article. Review.
-
Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells.PLoS One. 2012;7(1):e30264. doi: 10.1371/journal.pone.0030264. Epub 2012 Jan 18. PLoS One. 2012. PMID: 22279576 Free PMC article.
-
Functional roles of cytokines in infectious disease associated colorectal carcinogenesis.Mol Biol Rep. 2022 Feb;49(2):1529-1535. doi: 10.1007/s11033-021-07006-4. Epub 2022 Jan 4. Mol Biol Rep. 2022. PMID: 34981335 Review.
-
A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody.Am J Transplant. 2012 Feb;12(2):313-21. doi: 10.1111/j.1600-6143.2011.03836.x. Epub 2011 Nov 9. Am J Transplant. 2012. PMID: 22070565 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous